Please find enclosed herewith intimation for closure of trading window.

To, Dated: - September 28, 2026 The Manager, Department of Corporate Services, BSE Limited, Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai-400001 Scrip Code: 539206 Symbol: GVBL Subject: Closure of Trading Window Dear Sir/Madam, Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and in accordance with the code of Conduct to Regulate, Monitor and Report Trading by Designated persons for trading in company’s shares/securities, the trading window shall remain closed with effect from 01st October, 2026 for the purpose of consideration of the un-audited Financial Results of the Company for the quarter and half year ended on September 30, 2026. The trading window shall remain closed till 48 hours after the announcement of the said financial results, when the information becomes generally available. During the aforesaid closed trading window period, the Employees, Directors, Key managerial Personnel and Designated persons and their immediate relatives shall not trade in Company’s Shares/Securities. The date of the Board Meeting for declaration of the un-Audited Financial Results for the quarter and half year ended on September 30, 2026, will be intimated in due course. This is for your information and record please. Thanking you. Yours sincerely, For Genomic Valley Biotech Limited Yogesh Agrawal Managing Director DIN: 01165288